Gneb®-V

Therapeutic Segment:
Anti-hypertensive

Generic Name:
Nebivolol+Valsartan

Description:
Gneb®-V tablets contain nebivolol hydrochloride as one of two active ingredients. Nebivolol hydrochloride is present as a racemic mixture of d-Nebivolol hydrochloride and l-Nebivolol hydrochloride with the stereochemical designations of [SRRR]-nebivolol hydrochloride and [RSSS]-nebivolol hydrochloride, respectively.

Indication:
Nebivolol+Valsartan are beta adrenergic blocker and an angiotensin II receptor blocker (ARB) respectively indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.

Formulation:

• Tablets

Strength:

• 5mg + 80mg

Pack Size:

• 20’s